Penbraya Disease Interactions
There is 1 disease interaction with Penbraya (meningococcal group acwy conjugate-group b vaccine (cvx 316)).
Moderate
Meningococcal conjugate vaccine (applies to Penbraya) GBS
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Guillain-Barre Syndrome
Persons previously diagnosed with Guillain-Barre syndrome (GBS) may be at increased risk of GBS following receipt of meningococcal conjugate vaccine. The decision to give this vaccine should take into account the potential benefits and risks.
Switch to professional interaction data
Penbraya drug interactions
There are 298 drug interactions with Penbraya (meningococcal group acwy conjugate-group b vaccine (cvx 316)).
Report options
QR code containing a link to this page
More about Penbraya (meningococcal group acwy conjugate-group b vaccine (cvx 316))
- Penbraya consumer information
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bacterial vaccines
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
